Discover the most recent news about our Company.
Dr. Amor and collaborators have published a new article in the Diabetes Research and Clinical Practice journal using our plasma
Biosfer Teslab ha rebut per part de la Cambra de Comerç de Reus una ajuda competitiva Xpande Digital 2020 per
Biosfer Teslab has received from the Cambra de comerç de Reus an Xpande Digital 2020: a competitive call for international
Abstract The sizes of certain types of lipoprotein particles have been associated with an increased risk of cardiovascular disease. However,
Abstract Determining the concentration and size of lipoprotein complexes is very important due to their role in cardiovascular diseases and
Abstract Polycystic ovary syndrome (PCOS) is a variable disorder characterized by a broad spectrum of anomalies, including hyperandrogenemia, insulin resistance,
Last year we published 19 scientific articles in international journals. We are a metabolomics company halfway between research and clinical
Recentment la nostra CEO, Núria Amigó, va ser convidada a participar en el primer INNOWWIDE Focus Group, una trobada virtual
Recently our CEO, Núria Amigó, was invited to participate in the first INNOWWIDE Focus Group, a virtual meeting organized by
El grup de recerca en Immunologia de la Universitat d’Oviedo del qual forma part el Dr. Javier Rodríguez-Carrio ha publicat
The research group in Immunology at the University of Oviedo with the participation of Dr. Javier Rodríguez-Carrio has published a
Our lipoprotein profile, Liposcale (CE), in Cardiovascular Diabetology: “Advanced lipoprotein profile disturbances in type 1 diabetes mellitus: a focus on